Oregon medical students tested on delivering bad news

Telling families their loved one has died or admitting a medical error isn’t an easy conversation. But students at the Oregon Health & Science University (OHSU) will now have to be tested on it in a first-ever requirement for any medical school.

Kaiser Health News reports the requirement has been advocated by Susan Tolle, MD, director for OHSU’s Center for Ethics in Health Care. She said she’s seen physicians avoid eye contact, resort to medical jargon or generally lack basic compassion when dealing with patients and their families. In one example, she said she’s heard physicians say something like, “You need to call a funeral home.”

“My generation of faculty were not taught,” she said. “I had history-taking, but it was more about, ‘How long have you had chest pain?’ I did not have [instruction in] how to give bad news.’”

The new lessons and standards for communication and ethics focus on conversations like telling a patient they have a serious or even fatal illness. While the Association of American Medical Colleges requires some instruction in communication skills to be accredited, OHSU’s approach is new.

Most OHSU students passed the test, Tolle said, though some will need additional coaching. Common mistakes were failing to introduce themselves properly or ask what families already knew, along with quickly—and bluntly—saying that a patient is dead.

“You watched the screen and it looked like you hit [the spouse] with a truck,” Tolle said. “It comes across as incredibly uncaring.”

Read more at the link below:

""
John Gregory, Senior Writer

John joined TriMed in 2016, focusing on healthcare policy and regulation. After graduating from Columbia College Chicago, he worked at FM News Chicago and Rivet News Radio, and worked on the state government and politics beat for the Illinois Radio Network. Outside of work, you may find him adding to his never-ending graphic novel collection.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.